A nurse holds a COVID-19 vaccine in Miami, Fla., in this file photograph. Joe Raedle/Getty ImagesPfizer reported a decline in revenue on Nov. 4, which it primarily attributed to lower sales for the company’s COVID-19 vaccine, Comirnaty, and COVID-19 drug, Paxlovid.The company said it made $16.7 billion in revenue in the third quarter, down 7 percent from Q3 2024.
18.7
C
Ottawa
Wednesday, August 19, 2026
The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.
More from CN
Contact
© The Alliance Media Group design by CODEUS